The FDA’s Center for Drug Evaluation and Research (CDER) has announced the launch of its new Center for Real-World Evidence Innovation (CCRI), which aims to coordinate, advance and promote the use of real-world data (RWD) and real-world evidence (RWE) in regulatory decision-making across CDER.
According to the FDA, the CCRI will be a ‘collaborative core for innovation’ and a focal point to ensure the CDER promotes consistency and transparency on topics related to RWD and RWE.
Read more about the aims of the new centre and how it will generate evidence that provides valuable insights into the safety and effectiveness of medical products.